CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Series B Preferred Stocks [Member]	Series C Preferred Stocks [Member]	Series H Preferred Stocks [Member]	Series I Preferred Stocks [Member]	Common Stock [Member]	Treasury Stock, Common [Member]	Share To Be Cancelled [Member]	Stock Loan Receivable [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2022					$ 15,356	$ (643,059)		$ (7,610,147)	$ 288,664,858	$ (298,232,829)	$ (1,025,088)	$ (18,830,908)
Beginning balance, shares at Dec. 31, 2022	45,000	700	20,000		1,535,593,440	1,040
Common stock issued for conversions					$ 12,945				390,603			403,548
Common stock issued for conversions, shares					1,294,508,379
Fair value of derivative liability due to conversions									316,223			316,223
Common stock issued for Service					$ 1,000				79,000			80,000
Common stock issued for service, shares					100,000,000
Net loss										(5,680,068)	50,355	(5,629,713)
Ending balance, value at Mar. 31, 2023					$ 29,301	$ (643,059)		(7,610,147)	289,450,684	(303,912,897)	(974,733)	(23,660,850)
Ending balance, shares at Mar. 31, 2023	45,000	700	20,000		2,930,101,819	1,040
Beginning balance, value at Dec. 31, 2023					$ 102,538	$ (11,059)	$ (632,000)	(7,610,147)	293,069,829	(315,993,294)	(1,036,249)	(32,110,382)
Beginning balance, shares at Dec. 31, 2023	45,000	700	20,000	1,000	10,253,695,062	8	1,032
Common stock issued for conversions					$ 65,595				491,965			557,560
Common stock issued for conversions, shares					6,559,534,118
Fair value of derivative liability due to conversions									694,919			694,919
Tokenize investment reclassification									(1,666)
Net loss										7,161,989	(2,100)	7,159,889
Ending balance, value at Mar. 31, 2024					$ 168,133	$ (11,059)	$ (632,000)	$ (7,610,147)	$ 294,256,713	$ (308,831,305)	$ (1,038,349)	$ (23,699,674)
Ending balance, shares at Mar. 31, 2024	45,000	700	20,000	1,000	16,813,229,180	8	1,032